Cargando…
VALCOR: a protocol for the validation of SARS-corona virus-2 assays
BACKGROUND: Testing for SARS-CoV-2, together with vaccination, is one of the most vital strategies in curbing the current COVID-19 pandemic. The pandemic has led to an unprecedented need for diagnostic testing and the rapid emergence of an abundance of commercial assays on the market. Due to the nat...
Autores principales: | Arbyn, Marc, Dhillon, Sharonjit Kaur, Martinelli, Marianna, Simoens, Cindy, Cuypers, Lize, Bode, Jannes, Van Ranst, Marc, Corbisier, Philippe, Bonde, Jesper, Cocuzza, Clementina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962941/ https://www.ncbi.nlm.nih.gov/pubmed/35351191 http://dx.doi.org/10.1186/s13690-022-00869-4 |
Ejemplares similares
-
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
por: Dhillon, Sharonjit K., et al.
Publicado: (2023) -
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2022) -
Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021) -
Attendance at Cervical Cancer Screening and Use of Diagnostic and Therapeutic Procedures on the Uterine Cervix Assessed from Individual Health Insurance Data (Belgium, 2002-2006)
por: Arbyn, Marc, et al.
Publicado: (2014) -
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)